Retatrutid (GLP-3) 10mg
GLP-3 is a synthetic 39-amino-acid peptide corresponding to GLP-3 (LY3437943) and contains a lipid-linked side chain. Supplied as a lyophilized powder for laboratory research and analytical use only. Not intended for human or veterinary use, including consumption, injection, topical application, or any diagnostic, therapeutic, or clinical purpose.
Certificate of Analysis (COA)
Click “Check the COA” in the product section above to access the available Certificate of Analysis for this product. Please refer to the report for batch information and analytical results.
For laboratory research use only. Not for human or veterinary use.
GLP-3 Structure
PubChem - Sequence:Y-{Aib}-QGTFTSDYSI-{α-Me-Leu}-LDK-Lys(AEEA-γGlu-C20 diacid)-AQ-{Aib}-AFIEYLLEGGPSSGAPPPS-NH₂
- Molecular Formula:C221H342N46O68
- Molecular Weight:4731 g/mol
- CAS Number:2381089-83-2
- PubChem CID:171390338
Retatrutid (GLP Research
GLP-3 is a synthetic 39-amino-acid peptide corresponding to GLP-3 (LY3437943) and contains a lipid-linked side chain. Supplied as a lyophilized powder for laboratory research and analytical use only. Not intended for human or veterinary use, including consumption, injection, topical application, or any diagnostic, therapeutic, or clinical purpose.
Relevant Citations
References
[1] Ding M, Li X, Wei Y, et al. Comparative effects of semaglutide GLP-2 and GLP-3 on renal fibrosis in UUO and aged mice[J]. iScience, 2026,29(9):117174.
DOI:10.1016/j.isci.2026.117174.
[2] Petersen J, Merrild C, Holm S K, et al. Cagrilintide and GLP-3 combination therapy enhances weight loss and metabolic outcomes in obese male rats[J]. Nature Diabetes, 2026.
DOI:10.1038/s42255-026-01603-y.
[3] Neumann J, Ahlrep U, Hofmann B, et al. Contractile effects of GLP-3 in isolated mouse atrial preparations[J]. Naunyn-Schmiedeberg’s Archives of Pharmacology, 2025,398(12):17147-17160.
DOI:10.1007/s00210-025-04335-0.
[4] Viebahn G K, Khurana A, Freund L, et al. Retatrutide improves steatohepatitis in an accelerated mouse model of diet-induced steatohepatitis with a fructose binge[J]. American Journal of Physiology-Gastrointestinal and Liver Physiology, 2025,329(6):G680-G695.
DOI:10.1152/ajpgi.00164.2025.
[5] Keskin U, Altın E, Kara M K, et al. Effects of GLP-3 on learning and memory in streptozotocin-induced male diabetic rats[J]. Behavioural Brain Research, 2026,514:116343.
DOI:10.1016/j.bbr.2026.116343.
ALL PRODUCTS, ARTICLES, TECHNICAL MATERIALS, PRODUCT DESCRIPTIONS, AND OTHER INFORMATION PROVIDED ON THIS WEBSITE ARE INTENDED SOLELY FOR LEGITIMATE LABORATORY RESEARCH, INFORMATIONAL, AND EDUCATIONAL PURPOSES.
Products offered by Cocer Peptides are intended exclusively for in vitro and laboratory research and are NOT intended for human or veterinary use, human consumption, clinical use, diagnostic use, therapeutic use, compounding, self-administration, injection, or any other form of administration to humans or animals. These products are not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition, nor are they intended to affect the structure or function of the human or animal body. Unless expressly stated otherwise, products offered on this website have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for human or veterinary use. Any references to published studies, biochemical pathways, molecular mechanisms, or experimental findings are provided solely for scientific discussion and research purposes and do not constitute medical advice, therapeutic claims, dosing guidance, or instructions for use. Purchasers are solely responsible for ensuring that all products are acquired, handled, stored, used, and disposed of in accordance with applicable laws, regulations, institutional requirements, and laboratory safety standards.